These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 34344008)
61. Chemo-embolization for unresectable hepatocellular carcinoma with different sizes of embolization particles. Amesur NB; Zajko AB; Carr BI Dig Dis Sci; 2008 May; 53(5):1400-4. PubMed ID: 18046645 [TBL] [Abstract][Full Text] [Related]
62. Clinical evaluation of transcatheter arterial chemoembolization with 2-day-soluble gelatin sponge particles for hepatocellular carcinoma-comparison with insoluble gelatin sponge particles. Kawai N; Sato M; Minamiguchi H; Ikoma A; Sanda H; Nakata K; Sato H; Sakaguchi H; Nakai M; Sonomura T J Vasc Interv Radiol; 2013 Sep; 24(9):1383-90. PubMed ID: 23727419 [TBL] [Abstract][Full Text] [Related]
63. Transarterial chemoembolization for hepatocellular carcinoma: An old method, now flavor of the day. Boulin M; Delhom E; Pierredon-Foulongne MA; Cercueil JP; Guiu B Diagn Interv Imaging; 2015 Jun; 96(6):607-15. PubMed ID: 25998996 [TBL] [Abstract][Full Text] [Related]
64. Transarterial Embolization for Hepatocellular Carcinoma: A Comparison between Nonspherical PVA and Microspheres. Scaffaro LA; Kruel CD; Stella SF; Gravina GL; Machado Filho G; Borges de Almeida CP; Pinto LC; Alvares-da-Silva MR; Kruel CR Biomed Res Int; 2015; 2015():435120. PubMed ID: 26413523 [TBL] [Abstract][Full Text] [Related]
65. Hypoxic targeting and activating TH-302 loaded transcatheter arterial embolization microsphere. Ma P; Chen J; Qu H; Li Y; Li X; Tang X; Song Z; Xin H; Zhang J; Nai J; Li Z; Wang Z Drug Deliv; 2020 Dec; 27(1):1412-1424. PubMed ID: 33096947 [TBL] [Abstract][Full Text] [Related]
67. Superselective Chemoembolization of HCC: Comparison of Short-term Safety and Efficacy between Drug-eluting LC Beads, QuadraSpheres, and Conventional Ethiodized Oil Emulsion. Duan F; Wang EQ; Lam MG; Abdelmaksoud MH; Louie JD; Hwang GL; Kothary N; Kuo WT; Hofmann LV; Sze DY Radiology; 2016 Feb; 278(2):612-21. PubMed ID: 26334787 [TBL] [Abstract][Full Text] [Related]
68. Angiographic evaluation of hepatic arterial damage after transarterial chemoembolization for hepatocellular carcinoma. Maeda N; Osuga K; Mikami K; Higashihara H; Onishi H; Nakaya Y; Tatsumi M; Hori M; Kim T; Tomoda K; Nakamura H Radiat Med; 2008 May; 26(4):206-12. PubMed ID: 18509720 [TBL] [Abstract][Full Text] [Related]
69. Superselective Conventional Transarterial Chemoembolization for Hepatocellular Carcinoma: Rationale, Technique, and Outcome. Miyayama S; Matsui O J Vasc Interv Radiol; 2016 Sep; 27(9):1269-1278. PubMed ID: 27345337 [TBL] [Abstract][Full Text] [Related]
70. Efficacy and Safety of Drug Eluting Bead TACE with Microspheres <150 μm for the Treatment of Hepatocellular Carcinoma. Sattler T; Bredt C; Surwald S; Rust C; Rieger J; Jakobs T Anticancer Res; 2018 Feb; 38(2):1025-1032. PubMed ID: 29374736 [TBL] [Abstract][Full Text] [Related]
71. Current concepts in transarterial chemoembolization of hepatocellular carcinoma. Huppert P Abdom Imaging; 2011 Dec; 36(6):677-83. PubMed ID: 21674193 [TBL] [Abstract][Full Text] [Related]
72. Biodegradable mitomycin C microspheres given intra-arterially for inoperable hepatic cancer. With particular reference to a comparison with continuous infusion of mitomycin C and 5-fluorouracil. Fujimoto S; Miyazaki M; Endoh F; Takahashi O; Okui K; Morimoto Y Cancer; 1985 Nov; 56(10):2404-10. PubMed ID: 2412682 [TBL] [Abstract][Full Text] [Related]